Apis Active Pharmaceutical Ingredients Naftopidil CAS 57149-07-2

Name: Apis Active Pharmaceutical Ingredients Naftopidil CAS 57149-07-2
Brand: Fuzhou FUL Fluid Equipment & Pharmaceutical Co., Ltd.
SKU: 1910633902

Fujian, ChinaFuzhou FUL Fluid Equipment & Pharmaceutical Co., Ltd.

US$55.00

1,000-4,999 kg

US$54.00

5,000-9,999 kg

US$52.00

10,000+ kg

Sample price:US$100.00/kg.Request sample

Product profile

Powder

Yes

Certification

GMP, ISO 9001, USP, BP

Suitable for

Elderly, Children, Adult

Model NO.

FUL-PID004

State

Solid

CAS

57149-07-2

Mf

C24h28n2o3

Fw

392.49

Description

Ingredients Naftopidil

Character

Powder

Packaging

Drum

Transport Package

Drum

Specification

25kgs/drum

Origin

China

Production Capacity

100000000kgs/Month

Company profile

Fuzhou FUL Fluid Equipment & Pharmaceutical Co., Ltd.Fujian, China

CertifiedBusiness Type: Manufacturer/Factory CertifiedCustomization Options: Customization from SamplesExport Year: 2008-01-01 CertifiedNearest Port: Fuzhou PortAverage Response Time: ≤24h CertifiedTerms of Payment: LC, T/T

AI-Powered supplier vetting

SummaryThe supplier is a biotechnology and pharmaceutical equipment enterprise engaged in equipment R&D, production, construction, biotechnology development and transfer, and cooperative drug and vaccine production. Its stated product scope is medical fluid equipment, with related keywords covering pharmaceutical and vaccine production lines, intermediates, APIs, and finished drug preparations. It has a 5,000 m² manufacturing plant and exports 41%–50% of total sales, including through agents. Evidence indicates quality assurance, but no written procedures or records for service assessment, corrective and preventive actions, or complaint handling. The supplier does not provide ODM, 3D software design, SDKs, overseas warehouses, overseas showrooms, overseas agents or branches, and has not attended offline trade shows. It offers sample-based customization. Financial records are indicated for 2022–2024, but no assessable financial figures are provided.

Supplier typeThe supplier is described as a comprehensive biotechnology and pharmaceutical equipment enterprise integrating R&D, production, construction, biotechnology transfer, and cooperative drug and vaccine production. Its stated product scope is medical fluid equipment, supported by keywords covering pharmaceutical and vaccine production lines and related pharmaceutical products.

After-Sales capabilityThe supplier has no written procedures or records for service-capability assessment, corrective and preventive actions, or effective customer-complaint handling. It also reports no overseas warehouse, showroom, overseas agent or branch, while its stated peak- and off-season lead time is one month.

R&D capabilityThe supplier reports no professional technical-supplier R&D capability, no 3D software design service, no available SDK, no ODM service, and no new products during the past year. Its company description does mention R&D and biotechnology development, but the explicit capability responses indicate limited demonstrated innovation services.

Production capacityThe supplier states that it integrates equipment production and construction and operates a 5,000 m² manufacturing plant. Its business and product information is aligned with pharmaceutical and medical fluid equipment, although the provided slices do not quantify production capacity, equipment, or output.

Customization capabilityThe supplier explicitly provides customization from samples, demonstrating a sample-based customization capability. No evidence is provided for broader engineering, ODM, or 3D-design customization, and ODM is explicitly unavailable.